Skip to content

Effectiveness of a digital peer supported app based program to prevent diabetes complications: a prospective observational study

A prospective observational study evaluating the effectiveness of a digital peer-support app-based program to prevent diabetes complications - DPSA-DM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060828
Enrollment
300
Registered
2026-03-05
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus and prediabetes

Interventions

None listed

Sponsors

Kitasato University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Age 20 to 64 years. - Having undergone a specific health checkup or comprehensive medical checkup, or having visited a medical institution within the past year, with available clinical laboratory results. -Lifestyle-related diabetes or prediabetes, defined as follows: - For individuals who have visited a medical institution: HbA1c 6.0 to 8.9, or blood glucose < 250 mg/dL regardless of fasting/random status. - For individuals who have not visited a medical institution: HbA1c 6.0 to 6.9, or fasting plasma glucose 110 to <140 mg/dL, or random plasma glucose 140 to 199 mg/dL.

Exclusion criteria

Exclusion criteria: -Non-lifestyle-related diabetes/prediabetes (e.g., pancreatic disease, endocrine/hormonal disorders, drug-induced). -Type 1 diabetes or receiving insulin therapy. -Diabetic kidney disease, chronic renal failure, or undergoing dialysis. -Cardiovascular disease (e.g., angina, myocardial infarction, heart failure) or stroke. -Prohibited from exercise by a physician, or history of severe hypoglycemia that cannot be adequately self-managed. -Pregnancy. -Grade 2 hypertension or higher. -Dyslipidemia (LDL-C >= 180 mg/dL or triglycerides >= 500 mg/dL). Note: Lipid-based exclusion applies only to individuals who have not visited a medical institution.

Design outcomes

Primary

MeasureTime frame
Changes in lifestyle behaviors (diet, physical activity, smoking, alcohol consumption, and sleep) and medication status/adherence assessed at baseline (program start), 3 months (midpoint), and 6 months (program end).

Countries

Japan

Contacts

Public ContactShota Yoshihara

Kitasato University Medical Sciences

yoshihara.shota@st.kitasato-u.ac.jp042-778-9305

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026